DIA413.14+5.72 1.40%
SPX5,686.55+82.41 1.47%
IXIC17,999.10+288.36 1.63%

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga·04/30/2025 17:05:40
Listen to the news

Gainers

  • Regulus Therapeutics (NASDAQ:RGLS) shares increased by 132.5% to $7.83 during Wednesday's regular session. The company's market cap stands at $519.0 million.
  • Regencell Bioscience (NASDAQ:RGC) stock increased by 71.13% to $54.08. The company's market cap stands at $703.7 million.
  • INVO Fertility (NASDAQ:IVF) shares increased by 62.72% to $2.62. The company's market cap stands at $12.9 million. As per the press release, Q4 earnings came out 2 days ago.
  • Abeona Therapeutics (NASDAQ:ABEO) shares moved upwards by 30.18% to $6.9. The market value of their outstanding shares is at $334.8 million.
  • Nutriband (NASDAQ:NTRB) stock increased by 24.26% to $7.06. The company's market cap stands at $78.3 million.
  • Brainstorm Cell (NASDAQ:BCLI) stock rose 20.73% to $1.31. The market value of their outstanding shares is at $7.4 million.

Losers

  • GeneDx Holdings (NASDAQ:WGS) stock declined by 38.7% to $71.69 during Wednesday's regular session. The company's market cap stands at $2.0 billion. As per the news, the Q1 earnings report came out today.
  • NanoVibronix (NASDAQ:NAOV) stock decreased by 23.59% to $2.83. The company's market cap stands at $2.3 million.
  • Coeptis Therapeutics (NASDAQ:COEP) stock declined by 21.78% to $7.76. The market value of their outstanding shares is at $25.1 million.
  • Zynex (NASDAQ:ZYXI) stock fell 21.53% to $1.75. The market value of their outstanding shares is at $52.8 million. The company's, Q1 earnings came out yesterday.
  • Immunic (NASDAQ:IMUX) shares decreased by 15.63% to $1.08. The company's market cap stands at $103.4 million.
  • Cellectar Biosciences (NASDAQ:CLRB) shares fell 15.54% to $0.25. The market value of their outstanding shares is at $11.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.